Company intelligence / Profile preview

AUM Biosciences

Singapore, Singaporeaumbiosciences.com ↗

Ownership: Private
Employees: ~50
Development stage: Other

Overview

AUM001 has received Human Research Ethics Committee approval to commence Phase II clinical trial for metastatic colorectal cancer in Australia as of November 2022. The compound is a selective MNK inhibitor showing synergy potential especially when combined with Roche’s anti-PD-L1 therapy atezolizumab across multiple solid tumor indications. The pipeline demonstrates multi-faceted inhibition strategies aimed at reversing cancer resistance[1][2][3].

Therapeutic areas: Oncology
Modalities: Small molecule kinase inhibitors (e.g., MNK inhibitor, pan-PIM kinase inhibitor)Precision oncology therapeutics with multi-faceted inhibition strategies
Industry: Biotech

Drug pipeline

4 assets

tinodasertib

3 more assets in the full pipeline.

Partnerships

Major partnership with Roche to develop combination therapies involving their anti-PD-L1 antibody atezolizumab alongside their own compounds such as Aum001[3].

Beyond the preview

Go deeper on AUM Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AUM Biosciences.